Replies to post #5238 on Aurinia Pharmaceuticals Inc (AUPH)

[Jesspro]

If Glickman's wish should happen (going-it-alone), this baby will be more than a12 bigger from its price today. That possibility is very real because the market pundits wouldn't have any clue whether the cat will be dead or alive before the end of the p3 trial unless there is a leak. It's better for the pundits to advocate a BO now while it is cheap because stats are on their side that there is a Better than 70% chance of it being successful...jmo.

[grandma_of_jbraika]

Peter Lynch: "If you like a stock at $14 and it goes to $8, that's good if you understand the company. Take advantage of these declines. If you own good companies, you'll do well. It's always going to be scary, there's going to be always something to worry about, and you just have to forget about all of that. Know what you own and know why you own it." Isn't Aurinia a good company given it has many +'s & its revenue is conservatively estimated to be $4B by 2022? - https://en.wikipedia.org/wiki/Peter_Lynch

I don't set stop loss. I don't buy on margin. I don't sell. I add more when it pulls back. What can the manipulators/shorts or their employees such as ... do to my AUPH shares and my money? Ah? AUPH has very bright future. Patience is the key. I believe AUPH will be my next ARIA. I buy and hold AUPH the way I bought and held ARIA. I'm planning to add more AUPH shares now that the Glickman-Cramer interview has offered a new opportunity. I always picked/pick up the gold bags of ARIA/AUPH shares whenever the price was/is right to me. I like cheapened gold bags.

- This is posted by ariadinvestor: https://finance.yahoo.com/quote/AUPH/community?p=AUPH

zzaatt replied to me:

I read your posts as well. I like your intuitions on
picking a good investment (with a little help from vidpok,
at least for me), AND your dogged stubborness in sticking
with your convictions. It's not a guarantee that it will work
out, BUT is sure did with Ariad, and I believe it will also
have similar results here (minus the drama there).

I cannot think of another biotech where the probability
for a favorable outcome is as good as AUPH. The people
running the show are top notch, have deep experience in
both the specific science (LN related issues), and the
business acumen based on a very similar (almost
the same) medical and business situation.

While it might take two years for approval, I think we'll
see upward movement before that, after all, Aurinia does
have other indications for Voc. and potential for deal-making.

Good luck to you and fellow longs,
zzaatt/amp

PS: This two year (blinded) wait seems pretty grotesque, given the
strong results in P2 and the fact that it will cost the lives
of thousands of very desperate patients. I always had a
profound contempt for the corrupt, hide-bound bureaucracy
known as the FDA and I'm hoping for big changes under Dr.Gottlieb!
Who knows, maybe some conditional approval may be possible,
it certainly should be, if the goal is to help sick people.

- https://investorshub.advfn.com/boards/read_msg.aspx?message_id=133437830